Uplizna®
Uplizna® (inebilizumab-cdon) is a prescription medicine used to treat neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
MANUFACTURER: Horizon Therapeutics |
CLASS: Monoclonal Antibody |
WHAT IT TREATS: Neuromyelitis optica spectrum disorder |
PRESCRIBED BY: Various |
HOW ADMINISTERED: Infusion |
FREQUENCY: 2 treatments, 2 weeks apart, then 1 every 6 months |
Length of infusion: 90 min |
FOR MORE INFORMATION: |
